Glycated haemoglobin (HbA 1c ) is considered the gold standard for assessing diabetes compensation and treatment. In addition, fortuitous detection of haemoglobin variants during HbA 1c measurement is not rare. Recently, two publications reported different conclusions on accuracy of HbA 1c value using capillary electrophoresis method in presence of haemoglobin J-Baltimore (HbJ). Here we describe the fortuitous detection of unknown HbJ using capillary electrophoresis for measurement of HbA 1c . A patient followed for gestational diabetes in our laboratory presented unknown haemoglobin on Capillarys 2 Flex Piercing analyser which was identified as HbJ. HbJ is not associated with haematological abnormalities. High Performance Liquid Chromatography methods are known to possibly underestimate HbA 1c value in the presence of this variant. This variant and its glycated form are clearly distinguished on electropherogram but HbJ was responsible for underestimating the true area of HbA 1c . Capillary electrophoresis is a good method for detecting HbJ but does not seem suitable for evaluation of HbA 1C value in patients in presence of HbJ variant.
Introduction
Glycated haemoglobin (HbA 1c ) is considered the gold standard for assessing diabetes compensation and treatment. In addition, fortuitous detection of haemoglobin variants during HbA 1c measurement is not rare. Recently, an analytical evaluation of Capillarys 2 Flex Piercing (C2FP, Sebia, Lisses, France) has been published, assessing the possible interference of the most common haemoglobin variants in African immigrants to the United States (1) . The authors concluded that those common African haemoglobin variants, notably heterozygous for haemoglobin S (HbS) or haemoglobin C (HbC), not only could be detected, but also do not interfere with HbA 1c results and do not impair the ability of HbA 1c to detect abnormal glucose tolerance on C2FP analyser. Although heterozygous for HbS or HbC are the most frequently encountered variants in France they are not the only ones (2) . In 2013, we introduced C2FP instrument to our clinical biology laboratory at Rouen University Hospital, France to perform HbA 1c . Herein we report a case of haemoglobin J-Baltimore detected by electropherogram and discuss the consequences of the presence of this haemoglobin variant on accurate interpretation of HbA 1c result obtained by C2FP analyser.
Materials and Methods
A 28-year-old pregnant woman at 29 weeks of amenorrhoea, with no medical history, was referred by her attending physician at our Department of Endocrinology for management of newly diagnosed gestational diabetes. An oral glucose tolerance test and HbA 1c measurements were done respectively on Cobas 8000 analyser (Roche, Meylan, France) and C2FP instrument (Sebia, Lisses, France) in our clinical biology laboratory at Rouen University Hospital to monitor her diabetes. Oral glucose tolerance test was performed with 75 g of glucose dissolved in 250 mL of water which was absorbed by the patient.
Results
Fasting glucose, 1 hour and 2 hour levels after glucose charge were measured respectively as 4.8, 10.1 and 8.5 mmol/L. We detected two peaks of unknown haemoglobin on electropherogram. The higher peak was quantified at 47.7%. The other peak, probably corresponding to a glycated form of the first, was quantified at 1.2% (Figure 1 ). C2FP software does not allow HbA 1c calculation because of insufficient separation between the peak of unknown haemoglobin and HbA 1c fraction. Therefore, the sample was tested by High Performance Liquid Chromatography (HPLC) Bio-Rad Variant II analyser (BioRad, Marnes-la-Coquette, France). HbA 1c was measured at 4.6% (27 mmol/mol) with the presence of an unknown peak in P3 window, the window on Variant's chromatogram where haemoglobin variant could be detected, quantified at 44.3%. The manufacturer's instructions define a cut-off in the window as 5% for detection of haemoglobin variant sample. The sample was analysed by the National Haemoglobinopathy Reference Laboratory (Créteil, France) which identified this haemoglobin as J-Baltimore beta 16(A13) Gly>Asp (HbJ 
Discussion
Fortuitous identification of haemoglobin variants during HbA 1c measurement is not common and requires screening expertise by the clinical pathologist (3). In our laboratory, we perform 12,000 tests for HbA 1c measurement per year and we identify approximately 30 cases of haemoglobin variant per year. HbJ was first described in 1963 by Baglioni and Weatherall in a black American family (4). Haematological abnormalities are not usually associated with this variant. The analytical impact of this rare variant is well known on HbA 1c measurement by HPLC (5, 6) . Only a few recent publications have been published on capillary electrophoresis (CE) methods (7, 8) . Barakat 
